CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 136 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $16,957,000 | 100.00% |
| Meditor Group Ltd | 5,800,000 | $14,326,000 | 2.16% |
| TSP Capital Management Group, LLC | 1,135,748 | $2,805,000 | 1.29% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 8,526,619 | $21,061,000 | 0.30% |
| Marcus Capital, LLC | 103,800 | $256,000 | 0.22% |
| Benchmark Capital Advisors | 64,800 | $160,000 | 0.13% |
| Vident Investment Advisory, LLC | 480,018 | $1,186,000 | 0.10% |
| Bellevue Group AG | 160,000 | $395,000 | 0.05% |
| NJ State Employees Deferred Compensation Plan | 100,000 | $247,000 | 0.05% |
| Virtus ETF Advisers LLC | 126,989 | $314,000 | 0.05% |